Qiang Ding Selected Research

phenanthridone

1/2018

PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Ding Research Topics

Disease

136	Neoplasms (Cancer) 01/2022 - 02/2002
55	Breast Neoplasms (Breast Cancer) 03/2022 - 08/2010
40	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 11/2008
29	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2008
25	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 03/2008
25	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 02/2002
17	Infections 01/2022 - 04/2002
14	Fibrosis (Cirrhosis) 01/2021 - 07/2009
11	Carcinogenesis 01/2021 - 12/2009
10	Carcinoma (Carcinomatosis) 03/2019 - 02/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 05/2012
7	COVID-19 04/2022 - 12/2020
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2020 - 07/2009
6	Non-Muscle Invasive Bladder Neoplasms 01/2018 - 04/2014
5	Kidney Neoplasms (Kidney Cancer) 01/2022 - 11/2015
5	Glioblastoma (Glioblastoma Multiforme) 03/2021 - 10/2003
5	Lung Diseases (Lung Disease) 01/2021 - 08/2010
5	Necrosis 10/2019 - 10/2012
4	Triple Negative Breast Neoplasms 05/2022 - 08/2012
4	Wounds and Injuries (Trauma) 04/2022 - 01/2014
4	Virus Diseases (Viral Diseases) 01/2022 - 09/2012
4	Inflammation (Inflammations) 03/2020 - 06/2003
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2013
4	Erectile Dysfunction 01/2018 - 06/2006
4	Hypoxia (Hypoxemia) 05/2017 - 11/2013
4	Astrocytoma (Pilocytic Astrocytoma) 05/2014 - 09/2002
4	Ureteral Calculi 09/2012 - 02/2007
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 02/2006
3	Idiopathic Pulmonary Fibrosis 01/2021 - 05/2010
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 01/2017
3	Hyperglycemia 01/2020 - 06/2013
3	Diabetes Mellitus 01/2020 - 06/2018
3	Adenocarcinoma 12/2019 - 02/2013
3	Body Weight (Weight, Body) 01/2019 - 07/2008
3	Reperfusion Injury 01/2018 - 10/2013
3	Lung Neoplasms (Lung Cancer) 10/2017 - 09/2014
3	Pain (Aches) 01/2017 - 06/2013
3	Liver Neoplasms (Liver Cancer) 03/2016 - 12/2014

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
21	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2009
20	MicroRNAs (MicroRNA)IBA 10/2021 - 08/2010
20	Messenger RNA (mRNA)IBA 01/2020 - 01/2004
14	Pharmaceutical PreparationsIBA 01/2022 - 02/2006
10	Biological ProductsIBA 01/2021 - 02/2011
10	Small Interfering RNA (siRNA)IBA 12/2020 - 10/2003
9	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2010
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 06/2011
8	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 05/2014
8	CytokinesIBA 01/2021 - 04/2010
8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 08/2010
7	Focal Adhesion Protein-Tyrosine KinasesIBA 03/2021 - 06/2003
7	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 01/2013
7	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2004
7	Transcription Factors (Transcription Factor)IBA 11/2017 - 12/2010
7	Phosphotransferases (Kinase)IBA 05/2017 - 10/2003
6	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2018
6	N-methyladenosineIBA 03/2022 - 01/2019
6	Hormones (Hormone)IBA 12/2017 - 01/2012
5	EnzymesIBA 10/2021 - 12/2009
5	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 12/2014
5	src-Family KinasesIBA 12/2020 - 10/2003
5	TriterpenesIBA 10/2018 - 12/2009
5	SaponinsIBA 10/2018 - 01/2014
5	AndrogensIBA 06/2018 - 01/2013
5	Cadherins (E-Cadherin)IBA 01/2018 - 06/2012
4	CateninsIBA 05/2022 - 12/2017
4	Sunitinib (Sutent)FDA Link 01/2022 - 11/2015
4	VaccinesIBA 12/2021 - 01/2016
4	IntegrinsIBA 03/2021 - 09/2002
4	MethyltransferasesIBA 01/2021 - 06/2012
4	CollagenIBA 01/2020 - 10/2003
4	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 09/2012
4	Epirubicin (Ellence)FDA LinkGeneric 01/2015 - 02/2002
4	Thymidine PhosphorylaseIBA 02/2014 - 01/2004
3	Therapeutic UsesIBA 01/2022 - 02/2011
3	ChemokinesIBA 10/2021 - 03/2016
3	Monoclonal AntibodiesIBA 01/2021 - 09/2002
3	Estrogens (Estrogen)FDA Link 01/2021 - 06/2014
3	Insulin (Novolin)FDA Link 01/2020 - 01/2017
3	Hematoxylin (Haematoxylon)IBA 12/2019 - 06/2012
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2019 - 06/2012
3	Estrogen ReceptorsIBA 01/2019 - 05/2015
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 01/2013
3	Tamoxifen FDA LinkGeneric 01/2019 - 08/2011
3	RhamnoseIBA 10/2018 - 01/2014
3	InterferonsIBA 01/2018 - 07/2013
3	Peptides (Polypeptides)IBA 01/2018 - 09/2002
3	VimentinIBA 01/2018 - 06/2012
3	tissue-factor-pathway inhibitor 2 (PP5)IBA 10/2017 - 03/2009
3	Gemcitabine FDA Link 07/2016 - 05/2012

Therapy/Procedure

52	Therapeutics 01/2022 - 03/2006
11	Drug Therapy (Chemotherapy) 01/2018 - 01/2012
5	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 09/2013 - 02/2007
5	Solid-State Lasers 09/2013 - 09/2006
4	Castration 12/2021 - 10/2014
4	Nephrectomy 03/2015 - 03/2010
4	Transplantation 01/2014 - 03/2006
3	Intravesical Administration 01/2018 - 03/2006
3	Perforator Flap 01/2017 - 06/2015
3	Cystectomy 04/2016 - 01/2007